The purpose of BowTiedBiotech is two-fold. Primarily, we aim to provide our scientist audience the tools to build a biotech company and ultimately translate their ideas into medicines for patients. Secondarily, biotech investors may find our weekly market updates and insights into the public AND private markets useful.
BowTiedBiotech is also an experiment which attempts to level the playing field by promoting equal opportunity. This concept stands in contrast to today’s bio-business model where the ability to raise investment capital is LARGELY based on reputation and contacts. We aim to pass our knowledge of building biotech companies onto the next generation of aspiring scientist/entrepreneurs, while reshaping a world in which results are valued over credentials – it is equal opportunity, unequal results.
Now, you are likely asking yourself, how is BowTiedBiotech qualified to provide such information? We have >20years of industry experience developing drugs, financing biotech companies and successfully exiting them via M&A or NASDAQ IPO. We remain actively involved in the industry and take pride in helping the next generation transform ideas into medicines.